🇺🇸 FDA
Patent

US 9404088

Chitosan-based non-viral methods for transfecting gut cells in vivo

granted A61KA61K47/36A61K48/0041

Quick answer

US patent 9404088 (Chitosan-based non-viral methods for transfecting gut cells in vivo) held by ENGENE, INC. expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ENGENE, INC.
Grant date
Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K47/36, A61K48/0041, A61K48/005, A61K48/0058